Pharmacokinetics and Tolerability of DA-8031, a Novel Selective Serotonin Reuptake Inhibitor for Premature Ejaculation in Healthy Male Subjects

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s126861
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Pharmacokinetics, Pharmacodynamics, and Tolerability of Verinurad, a Selective Uric Acid Reabsorption Inhibitor, in Healthy Japanese and Non-Asian Male Subjects

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of E3024, a Novel and Selective Dipeptidyl Peptidase-Iv Inhibitor, in Healthy Japanese Male Subjects: Rash Development in Men and Its Possible Mechanism

Pharmacology & Pharmacy
2013English

Drug Interaction of Fluvoxamine, a Selective Serotonin Reuptake Inhibitor

Folia Pharmacologica Japonica
Pharmacology
2006English

Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy Subjects

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2009English

Guidelines for Choice of Selective Serotonin Reuptake Inhibitor in Depressive Illness

Advances in Psychiatric Treatment
2001English

Selective Serotonin Reuptake Inhibitor–Induced Spermatorrhea in 2 Patients

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2009English

Deciding Which Selective Serotonin Reuptake Inhibitor to Prescribe

BMJ
1995English

Selective Serotonin Reuptake Inhibitor Associated Suicidal Ideation: A Case Report

International Journal of Basic & Clinical Pharmacology
2014English

Safety and Tolerability of Edivoxetine as Adjunctive Treatment to Selective Serotonin Reuptake Inhibitor Antidepressants for Patients With Major Depressive Disorder

Drugs in Context
Molecular MedicinePharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy